مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Assessing the cost-effectiveness of pharmacogenomics.
Normal view MARC view ISBD view

Assessing the cost-effectiveness of pharmacogenomics. [electronic resource]

By:
  • Veenstra, D L
Contributor(s):
  • Higashi, M K
  • Phillips, K A
Producer: 20020215Description: E29 p. digitalISSN:
  • 1522-1059
Subject(s):
  • Anticholesteremic Agents -- therapeutic use
  • Anticoagulants -- pharmacokinetics
  • Antimetabolites, Antineoplastic -- therapeutic use
  • Cardiovascular Diseases -- drug therapy
  • Carrier Proteins -- genetics
  • Child
  • Cholesterol Ester Transfer Proteins
  • Cost-Benefit Analysis
  • Drug Therapy -- economics
  • Genotype
  • Glycoproteins
  • Hepatitis C -- drug therapy
  • Humans
  • Interferons -- therapeutic use
  • Mercaptopurine -- therapeutic use
  • Methyltransferases -- deficiency
  • Pharmacogenetics -- economics
  • Pharmacology, Clinical -- economics
  • Phenotype
  • Pravastatin -- therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
  • Ribavirin -- therapeutic use
  • Warfarin -- pharmacokinetics
Online resources:
  • Available from publisher's website
In: AAPS pharmSci vol. 2
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Comparative Study; Journal Article

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 1 First report of somatic mosaicism for mutations in STK11 in four patients with Peutz-Jeghers syndrome.
    by McKay, Victoria
  • 2 Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years.
    by Anagnostopoulos, Antonios
  • 3 Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease.
    by Weedon, Michael N
  • 4 Genetic heterogeneity in LEOPARD syndrome: two families with no mutations in PTPN11.
    by Kalidas, Kamini
  • 5 Constitutional trisomy 8 and Behçet syndrome.
    by Becker, Kristin
  • 6 Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome.
    by Klopocki, Eva
  • 7 EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.
    by Pathak, Sagar J
  • 8 Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.
    by Bancroft, Elizabeth K
  • 9 TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism.
    by Harley, Margaret E
  • 10 Gene-gene interactions in breast cancer susceptibility.
    by Turnbull, Clare
  • 11 Germline mutations in RAD51D confer susceptibility to ovarian cancer.
    by Loveday, Chey
  • 12 Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes
    by Andrews, Katrina A
  • 13 Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes.
    by Whitworth, James
  • 14 Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.
    by Ruark, Elise
  • 15 Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus.
    by Beunders, Gea
  • 16 Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
    by Bancroft, Elizabeth K
  • 17 Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
    by Mikropoulos, Christos
  • 18 Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
    by Mikropoulos, Christos
  • 19 Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
    by Page, Elizabeth C
Close

Assessing the cost-effectiveness of pharmacogenomics.

APA

Veenstra D. L., Higashi M. K. & Phillips K. A. (20020215). Assessing the cost-effectiveness of pharmacogenomics. : AAPS pharmSci.

Chicago

Veenstra D L, Higashi M K and Phillips K A. 20020215. Assessing the cost-effectiveness of pharmacogenomics. : AAPS pharmSci.

Harvard

Veenstra D. L., Higashi M. K. and Phillips K. A. (20020215). Assessing the cost-effectiveness of pharmacogenomics. : AAPS pharmSci.

MLA

Veenstra D L, Higashi M K and Phillips K A. Assessing the cost-effectiveness of pharmacogenomics. : AAPS pharmSci. 20020215.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site